Trial site
Sendai
- 15running trials
- 11closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Lupus (SLE)3 trials
- Multiple sclerosis3 trials
- Myelodysplastic syndromes3 trials
- Chronic myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Myasthenia gravis2 trials
- Stroke2 trials
- Acute lymphoblastic leukaemia1 trial
- ANCA-associated vasculitis1 trial
- and 10 more
- Phase
- Phase 313 trials
- Phase 28 trials
- Status
- Active, not recruiting12 trials
- Completed8 trials
- Recruiting3 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals26 trials
Running trials
Active, not recruiting
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Recruiting
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Terminated
Completed
Terminated
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026